| # | Drug | Count |
|---|---|---|
| 0 | OMEPRAZOLE MAGNESIUM | 215 |
| 1 | LANSOPRAZOLE | 203 |
| 2 | ESOMEPRAZOLE MAGNESIUM | 155 |
| 3 | OMEPRAZOLE | 149 |
| 4 | PANTOPRAZOLE | 147 |
| 5 | FUROSEMIDE | 130 |
| 6 | ASPIRIN | 106 |
| 7 | ASPIRIN 325 MG | 104 |
| 8 | ASPIRIN 81 MG | 104 |
| 9 | PANTOPRAZOLE SODIUM | 100 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PAROMOMYCIN SULFATE | 4 | 0.0377 |
| 1 | FERROUS ASPARTO GLYCINATE, FERROUS FUMARATE, ASCORBIC ACID, FOLIC ACID, LEVOMEFOLATE GLUCOSAMINE, CYANOCOBALAMIN, ZINC GLYCINATE, AND INTRINSIC FACTOR | 2 | 0.0204 |
| 2 | FLAVOXATE HYDROCHLORIDE | 1 | 0.0099 |
| 3 | TOREMIFENE CITRATE | 3 | 0.0070 |
| 4 | DICLOFENAC SODIUM/MISOPROSTOL | 3 | 0.0068 |
| 5 | CETYLPYRIDINIUM CHLORIDE | 4 | 0.0061 |
| 6 | DOXERCALCIFEROL | 1 | 0.0060 |
| 7 | BECLOMETHASONE DIPROPIONATE | 24 | 0.0042 |
| 8 | BENZOCAINE AND DEXTROMETHORPHAN HYDROBROMIDE | 1 | 0.0040 |
| 9 | BENZOCAINE AND MENTHOL | 1 | 0.0038 |
| # | Drug class | Count |
|---|---|---|
| 0 | Proton Pump Inhibitor [EPC] | 280 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 210 |
| 2 | Corticosteroid [EPC] | 179 |
| 3 | Loop Diuretic [EPC] | 155 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 108 |
| 5 | Dihydropyridine Calcium Channel Blocker [EPC] | 100 |
| 6 | Benzodiazepine [EPC] | 92 |
| 7 | Angiotensin 2 Receptor Blocker [EPC] | 90 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 89 |
| 9 | beta-Adrenergic Blocker [EPC] | 89 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Melanocortin 4 Receptor Agonist [EPC] | 1 | 0.0035 |
| 1 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 6 | 0.0026 |
| 2 | Tricyclic Antidepressant [EPC] | 1 | 0.0021 |
| 3 | Provitamin D2 Compound [EPC] | 57 | 0.0019 |
| 4 | Paramagnetic Contrast Agent [EPC] | 8 | 0.0017 |
| 5 | Opioid Antagonist [EPC] | 1 | 0.0010 |
| 6 | Lipid-based Polyene Antifungal [EPC] | 13 | 0.0010 |
| 7 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 3 | 0.0009 |
| 8 | Blood Viscosity Reducer [EPC] | 4 | 0.0009 |
| 9 | CCR5 Co-receptor Antagonist [EPC] | 2 | 0.0009 |